Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients

Clinical trial NCT00137748 · COMPLETED

Trial details

NCT number: NCT00137748
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hypogammaglobulinemia

Start date: 2001-01-01
Primary completion: 2006-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.